Delivery Order SPE2DB25D3504-SPE2DB26FVTFZ
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Lisdexamfetamine 40 mg capsules (90-count) with a contract value of $1,625.77 and an ultimate completion date of October 22, 2025. This firm fixed price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The award was...
- The Defense Logistics Agency awarded a delivery order valued at $14,087.04 to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Lisdexamfetamine 70 mg capsules (90-count units). This is a firm fixed price, competitively awarded contract with no set-aside designation, scheduled for completion by September 15, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's...
- The Defense Logistics Agency awarded a $3,672.67 delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Lisdexamfetamine 40 mg capsules (100-count units). This is a firm fixed-price contract with an ultimate completion date of October 22, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation. This delivery order represents a child contract...
- The Defense Logistics Agency awarded a $1,437.63 delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Lisdexamfetamine 10 mg capsules (90-count units). This firm fixed-price delivery order, with an ultimate completion date of August 19, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract involves no set-aside designation and was competitively awarded. Performance will occur...
- The Defense Logistics Agency awarded a delivery order valued at $1,850.60 to AmerisourceBergen Drug Corp for the supply of Lisdexamfetamine 60 mg capsules (90-count units). The contract was awarded on September 23, 2025, with an ultimate completion date of September 24, 2025, using firm fixed pricing with no set-aside designation. Performance will be conducted at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order represents a competitive award issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of Lisdexamfetamine 50 mg capsules (90-count units) with a ceiling value of $8,109.38. This firm fixed-price delivery order, with an ultimate completion date of October 21, 2025, represents a non-set-aside competitive award to the pharmaceutical distributor's corporate office location in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Lisdexamfetamine 30 mg capsules (100-count units) with a ceiling value of $6,184.82. This is a firm fixed-price delivery order with no set-aside designation, issued under competitive procurement procedures. The contract is scheduled for ultimate completion on September 12, 2025, with performance taking place at AmerisourceBergen's facility in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Lisdexamfetamine 50 mg capsules (90-count units) with a ceiling value of $1,204.49. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The contract is set to be completed by September 26, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency (DLA) awarded a $2,681.68 delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Lisdexamfetamine 30 mg capsules in quantities of 100 units. This is a firm fixed price contract with an ultimate completion date of September 12, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract was competitively awarded with no set-aside designation and will...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Lisdexamfetamine 20 mg capsules (90-count) with a ceiling value of $29,095.35. This firm fixed-price, non-set-aside contract is scheduled for completion by September 17, 2025, and will be performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- SPE2DB25D3504Indefinite Delivery Contract
- SPE2DB25D3504-SPE2DB26FVTFZDelivery Order
The Defense Logistics Agency awarded a $2,898.76 firm fixed-price delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Lisdexamfetamine 50 mg capsules (90-count units). The contract, which is a non-set-aside award, is scheduled for completion on October 22, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement supporting military and veteran healthcare systems. The company's competitively awarded contracts with the Defense Logistics Agency demonstrate its extensive capability to supply a comprehensive range of pharmaceutical products across multiple therapeutic domains. This particular delivery order for Lisdexamfetamine, a medication commonly used in the treatment of attention deficit hyperactivity disorder, exemplifies the company's role in supplying specialized medications to support Defense Health Agency and other government healthcare systems through the flexible Pharmaceutical Prime Vendor Global Program structure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.9k | 10/21/25 |